ASC24
7.2.2024 10:31:30 CET | Business Wire | Press release
The preliminary results for the 2024 ASC Student Supercomputer Challenge (ASC24) have been announced. Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals. Among the finalists are renowned institutions such as Huazhong University of Science and Technology, Peking University, the Chinese University of Hong Kong, National Tsing Hua University, Friedrich-Alexander-University Erlangen-Nuremberg, and the National University of Cordoba. They will compete for prestigious awards including the Champion, Silver Prize, Group Competition Award, e Prize, and Highest LINPACK at the finals hosted by Shanghai University from April 9 to 13, 2024.
In response to the challenge posed by a large number of excellent teams, the ASC Organizing Committee, and Shanghai University have decided to accommodate 25 teams for the ASC24 Finals, setting a new record for the highest number of teams qualified for onsite finals since the inception of the ASC competition in 2012.
Among the finalists, Huazhong University of Science and Technology's team demonstrated an in-depth grasp of supercomputing knowledge and technologies. Through precise performance bottleneck analysis and innovative optimization methods, they achieved outstanding results. Their exceptional performance across all tasks secured them the top rank in the preliminary round.
The ASC24 finals feature a lineup of traditional powerhouses, including Peking University - the champion of the 10th ASC onsite finals; the Chinese University of Hong Kong - the champion of the 10th ASC virtual finals; University of Science and Technology of China; Shanghai Jiao Tong University; and Friedrich-Alexander-University Erlangen-Nuremberg. Additionally, there is great excitement surrounding the debut of teams from National University of Cordoba, Macau University of Science and Technology, and Southwest Petroleum University, marking their first appearance in the ASC finals this year.
The ASC24 preliminaries included two computational tasks: Large Language Model (LLM) Inference Optimization and Seepage Numerical Simulation. Numerous participating teams excelled, showcasing remarkable capabilities in exploring and innovating in supercomputing application analysis, performance optimization, and parallel strategy design.
In the Large Language Model (LLM) Inference Optimization Challenge, participating teams were assigned the task of building and refining inference engines using the widely used open-source LLM, LLaMA2. The main goal was to achieve high-throughput inference on sample datasets provided by the organizing committee. Teams contending for success were expected to showcase a thorough understanding and proficiency in common parallel methods applicable to LLMs. Furthermore, they were tasked with implementing various techniques to enhance the inference process.
The team from Huazhong University of Science and Technology developed an LLM inference engine that incorporated tensor parallelism, KVCache, and PagedAttention. Additionally, they implemented asynchronous pipelining in parallel to address the issue of incomplete loading of model parameters on a single server. Moreover, they deployed a distributed memory manager on each node to ensure load balancing and conducted numerous comparative experiments to identify the optimal optimization method. These efforts propelled them to achieve the highest score. On the other hand, the team from Friedrich-Alexander-University Erlangen-Nuremberg utilized a customized TensorRT-LLM engine for their cluster. Through various experiments, they determined that a batch size of 8 resulted in twice the throughput compared to a batch size of 1. By leveraging tensor parallelism and batched generation, they achieved good performance.
The Seepage Simulation Task in ASC24 was designed to delve into the intricate flow patterns and characteristics of multiphase fluids within porous media using the open-source software OpenCAEPoro. Participating teams were tasked with simulating the seepage of multiphase fluids, including oil, gas, and water, specifically in scenarios related to petroleum extraction, based on the dataset provided by the organizing committee. The challenge required teams to skillfully optimize large-scale parallel computing processes, with a focus on improving the computing performance and parallel efficiency of discrete algorithms.
The team from Qinghai University utilized common optimization methods, including function inlining, loop expansion, and operator fusion, after conducting a detailed analysis of the seepage simulation software OpenCAEPoro. They also implemented vectorization and memory access optimization to address computational bottleneck matrix assembly, resulting in highly effective optimization. Meanwhile, the National Tsing Hua University team conducted a comprehensive analysis of OpenCAEPoro, pinpointing the primary bottleneck for CPU parallelization. They leveraged optimized compiler flags and computing libraries to achieve the best performance.
About ASC
The ASC Student Supercomputer Challenge is the world's largest student supercomputer competition, sponsored and organized by the Asia Supercomputer Community with support from experts and institutions across Asia, Europe, and America. The main objectives of ASC are to encourage the exchange and training of young supercomputing talent from different countries, improve supercomputing applications and R&D capacity, boost the development of supercomputing, and promote technical and industrial innovation. The first ASC Student Supercomputer Challenge was held in 2012 and has since attracted over 10,000 undergraduates from all over the world. Learn more for ASC at http://www.asc-events.net/StudentChallenge/index.html.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240207108190/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
